INVO Fertility, Inc. operates as a revenue-generating fertility business. The company is headquartered in Sarasota, Florida and currently employs 28 full-time employees. The company went IPO on 2008-11-11. Its segments include Fertility Clinic Services, INVOcell Device, and Therapeutics. The company focuses on operating fertility clinics, including INVO Centers dedicated primarily to offering the intravaginal culture (IVC) procedure enabled by its INVOcell medical device (INVOcell) and United States-based, in vitro fertilization (IVF) clinics. The company has two operational INVO Centers in the United States and one IVF clinic. The company is also engaged in the sale and distribution of its INVOcell technology solution to third party-owned and operated fertility clinics. The INVOcell is a proprietary medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. The IVC procedure provides patients with a natural, intimate, and affordable experience.
Follow-Up Questions
Qui est le CEO de INVO Fertility Inc ?
Mr. Steven Shum est le Chief Executive Officer de INVO Fertility Inc, il a rejoint l'entreprise depuis 2017.
Quelle est la performance du prix de l'action IVF ?
Le prix actuel de IVF est de $0.8714, il a decreased de 0% lors de la dernière journée de trading.
Quels sont les thèmes d'affaires principaux ou les industries de INVO Fertility Inc ?
INVO Fertility Inc appartient à l'industrie Health Care et le secteur est Health Care
Quelle est la capitalisation boursière de INVO Fertility Inc ?
La capitalisation boursière actuelle de INVO Fertility Inc est de $3.7M
Est-ce que INVO Fertility Inc est un achat, une vente ou un maintien ?
Selon les analystes de Wall Street, 2 analystes ont établi des notations d'analystes pour INVO Fertility Inc, y compris 1 achat fort, 3 achat, 1 maintien, 0 vente et 1 vente forte
